Author:
Wu Ya Meng,Huang Luo yi,Ni Jing huan,Chen Xu kai,Tang Peng-Fei,Qian Jianchang,Xiao Zhong-xiang,Xu Huan hai
Reference21 articles.
1. Myelofibrosis: A review];A Genthon;Rev Med Interne,2021
2. Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management;A Tefferi;Am J Hematol,2023
3. First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with Myelofibrosis;S K De;Anticancer Agents Med Chem,2023
4. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management;A Tefferi;Am J Hematol,2021
5. The JAK-STAT pathway at 30: Much learned, much more to do;R L Philips;Cell,2022